Ventricular tachycardia during hyperthermic intraperitoneal chemotherapy

Anaesthesia

Volumn 64, Issue 10, 2009, Pages 1134-1136

  Thix, C A ^a   Konigsrainer I ^a   Kind, R ^a   Wied, P ^a   Schroeder, Torsten H ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; CISPLATIN; MAGNESIUM; CARBOPLATIN; FLUOXETINE; OLANZAPINE; PACLITAXEL; PROPOFOL; ROPIVACAINE; SEVOFLURANE; SUFENTANIL; TOPOTECAN; VERAPAMIL;

AGED; ANAMNESIS; ARTICLE; CANCER SURGERY; CASE REPORT; DRUG BLOOD LEVEL; ELECTROCARDIOGRAM; FEMALE; HEART ARRHYTHMIA; HEART VENTRICLE TACHYCARDIA; HOSPITAL DISCHARGE; HUMAN; HYPERTHERMIC THERAPY; INTENSIVE CARE UNIT; LABORATORY TEST; MAGNESIUM BLOOD LEVEL; PERITONEAL CAVITY; PERITONEUM TUMOR; TRANSTHORACIC ECHOCARDIOGRAPHY; BLADDER TUMOR; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CYTOREDUCTIVE SURGERY; DEPRESSION; HEART FAILURE; HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY; ILEOSTOMY; ILEUM RESECTION; OMENTECTOMY; OVARY CANCER; PERITONEUM METASTASIS; RECTUM ANTERIOR RESECTION; SPLENECTOMY; UTERUS SURGERY;

AGED; ANTINEOPLASTIC AGENTS; CHEMOTHERAPY, ADJUVANT; CISPLATIN; FEMALE; HUMANS; HYPERTHERMIA, INDUCED; INFUSIONS, PARENTERAL; PERITONEAL NEOPLASMS; TACHYCARDIA, VENTRICULAR;

EID: 70349342750     PISSN: 00032409     EISSN: 13652044     Source Type: Journal    
DOI: 10.1111/j.1365-2044.2009.05993.x     Document Type: Article

References (12)

1. Hashimi LA, Khalyl MF, Salem PA. Supraventricular tachycardia. A probable complication of platinum treatment. Oncology 1984; 41: 174-175
2. Hrovatin E, Viel E, Lestuzzi C, et al. Severe ventricular dysrhythmias and silent ischemia during infusion of the antimetabolite 5-fluorouracil and cis-platin. Journal of Cardiovascular Medicine 2006; 7: 637-640 (Pubitemid 44350500)
3. Tassinari D, Sartori S, Drudi G, et al. Cardiac arrhythmias after cisplatin infusion: three case reports and a review of the literature. Annals of Oncology 1997; 8: 1263-1267 (Pubitemid 28164083)
4. Sartori S, Nielsen I, Tassinari D, et al. Changes in intra-cellular magnesium concentrations during cisplatin chemo-therapy. Oncology 1993; 50: 230-234 (Pubitemid 23193910)
5. Markman M. Intraperitoneal antineoplastic drug delivery: rationale and results. Lancet Oncology 2003; 4: 277-283 (Pubitemid 36603295)
6. O'Dwyer PJ, Stevenson JP, Johnson SW. Clinical pharma-cokinetics and administration of established platinum drugs. Drugs 2000; 59 (Suppl. 4): 19-27.
7. Vermorken JB, van der Vijgh WJ, Klein I, et al. Pharma-cokinetics of free and total platinum species after short-term infusion of cisplatin. Cancer Treatment Reports 1984; 68: 505-513 (Pubitemid 14134099)
8. Yavas O, Aytemir K, Celik I. The prevalence of silent arrhythmia in patients receiving cisplatin-based chemo-therapy. Turkish Journal of Cancer 2008; 38: 12-15 (Pubitemid 351956277)
9. Rehm M, Haller M, Brechtelsbauer H, et al. Extra protein loss not caused by surgical bleeding in patients with ovarian cancer. Acta Anaesthesiologica Scandinavica 1998; 42: 39-46. (Pubitemid 28046736)
10. Schmidt C, Creutzenberg M, Piso P, et al. Peri-operative anaesthetic management of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Anaesthesia 2008; 63: 389-395
11. Simon HB. Hyperthermia. New England Journal of Medicine 1993; 329: 483-487
12. Howell SB, Pfeifle CL, Wung WE, et al. Intraperitoneal cisplatin with systemic thiosulfate protection. Annals of Internal Medicine 1982; 97: 845-851